期刊文献+

血浆抑制素在异位妊娠中的变化及临床意义 被引量:1

Changes of serum inhibin content in ectopic pregnancy and its clinical significance
暂未订购
导出
摘要 目的探讨血浆抑制素(inhibin,INH)在异位妊娠中的含量变化及临床意义。方法设置宫内妊娠组(26例)和异位妊娠组(18例),并设对照组,应用改良的INH放射免疫测定(RIA)方法测定早期宫内及异位妊娠血浆INH含量变化,并将血浆βhCG与INH浓度进行相关性分析。结果1.异位妊娠组血浆INH和βhCG均值小于宫内妊娠组,差异显著,P值均<0.05;2.宫内妊娠组血浆INH与βhCG间呈显著相关关系:r宫内=0.487,P<0.025;异位妊娠组,两者间无相关性,r异位=0.281,P>0.05。结论联合监测血浆INH及βhCG可作为异位妊娠的辅助诊断; Objective To investigate the changes of inhibin content in ectopic pregnancy and its clinical significance. Methods Twenty six cases of intrauterine pregnancy and Eighteen cases of ectopic pregnancy were choosen arbitrarily. Modified inhibin radioimmunoassay was used to measure the changes of plasma inhibin contents in both intrauterine and ectopic pregnancy. The correlation between serum β hCG and inhibin was analysed statistically. Results 1. The mean values of plasma levels of inhibin and β hCG in ectopic pregnancy were both lower than those in intrauterine pregnancy, the difference was significant, P <0.05; 2. In intrauterine pregnancy the correlation between plasma levets of inhibin and β hCG significant, r= 0.487, P <0.025; No correlation was present between plasma inhibin and β hCG in ectopic pregancy, r= 0.281, P >0.05.Conclusions Monitoring of both plasma levels of inhibin and β hCG would be helpful in the diagnosis of ectopic pregnancy and in evaluation of the condition of gestational corpora lutea and embryonic development.
出处 《上海医学》 CAS CSCD 北大核心 1999年第6期358-360,共3页 Shanghai Medical Journal
关键词 异位妊娠 Β-HCG 血浆抑制素 Inhibin Ectopic pregnancy Human chorionic gonadotropin β hCG subunit (β hCG).
  • 相关文献

参考文献5

  • 1隋龙.抑制素及其相关肽类物质在女性生殖调节中的作用[J].国外医学(妇产科学分册),1996,23(5):269-273. 被引量:5
  • 2隋龙 张令浩 等.改良的抑制素放射免疫测定及其对卵巢癌的检测作用[J].肿瘤,1998,18:322-322.
  • 3隋龙,肿瘤,1998年,18卷,322页
  • 4隋龙,国外医学.妇产科分册,1996年,23卷,269页
  • 5Khoury R H,J Clin Endocrinol Metab,1995年,80卷,1361页

共引文献4

同被引文献16

  • 1穆荣梅.母体血浆抑制素A水平对于先兆流产妊娠结局的预见[J].国外医学(计划生育分册),2004,23(4):235-235. 被引量:1
  • 2吕小梅.妊娠早期INHA和pro-αC检查及其在预测反复流产患者妊娠结局中的作用[J].国外医学(妇产科学分册),2004,31(6):383-383. 被引量:2
  • 3王国洪.抑制素测定的临床意义[J].标记免疫分析与临床,2004,11(4):238-240. 被引量:4
  • 4乐杰.妇产科学(第5版)[M].北京:人民卫生出版社,2001.139.
  • 5Luisi S , Fiorio P, Reis FM, et al. inhibins in female and male reproductive physiology : role in garnet ogenesis, conception, implantation and early pregnancy. Hum Reprod Update. 2004, 23 ( 11 )
  • 6Tong S, Rombauts L, Marjon A, et al. increased day 15 -17 serum pio-alphac inhibin leveis specific to successful pregnancy, J Clin Endocrinol Metab. 2004, 89 (9) : 4404
  • 7Lambert- messerlian GM, pinar H, Laprade E. Inhibins and activins in human fetal abnormalities. MolCell Endocrinol. 2004, 15 (1 -2) : 101
  • 8Wallace EM, Marjono B, Tyzack K, et al. First trimester levels of inhibins and activin A in normal and failing pregnancies. Clin Endocrinoi. 2004, 60 (4) : 484
  • 9Spencer K, Tul N, Nicoiaides KH, et al. Maternal serum free β- HCG and PAPP - A in fetal sex chromosome defects in the first trimester. Prenat Diagn , 2000, 20 : 390
  • 10Tul N, Spencer K, Noble P, et al. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β- HCG and PAPP - A at 10-14 weeks of gestating. Prenat Diagn, 1999, 19:1035

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部